Publications

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

 70
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

Tags:

Previous Article

ERK1/2 signaling targeting in cancer

Next Article

MAPK inhibition to protect against spinal muscular atrophy

Related Posts

Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells

Targeting RhoA nuclear mechanoactivity rejuvenates aged...

 50

Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement

Pseudouridine RNA avoids immune detection through impai...

 139

Development of a circadian immune system

Development of a circadian immune system

 104